BRIEF-Valeant announces changes to executive management team

Mon Aug 8, 2016 8:10am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 8 (Reuters) - Valeant Pharmaceuticals International Inc

* Valeant Pharmaceuticals announces changes to executive management team

* Anne Whitaker will also serve as EVP and company group chairman, leading our branded pharmaceuticals businesses

* Tom Appio will be promoted to evp and company group chairman, and will lead all of Valeant's markets outside United States And Canada

* Scott hirsch joins Valeant as senior vice president, business strategy and communications

* Christina Ackermann named executive vice president and general counsel

* Ari Kellen will serve as evp and company group chairman, and will lead Bausch & Lomb Business. Source text for Eikon: Further company coverage: